Hagemann, D. et al. 2000. Frequency-encoding Thr17 phospholamban phosphorylation is independent of Ser16 phosphorylation in cardiac myocytes. J Biol Chem. 275(29), pp.22532-6.
Huke, S. and Bers, D.M. 2007. Temporal dissociation of frequency-dependent acceleration of relaxation and protein phosphorylation by CaMKII. J Mol Cell Cardiol. 42(3), pp.590-9.
Isoda, T. et al. 2003. Novel regulation of cardiac force-frequency relation by CREM (cAMP response element modulator). Faseb Journal. 17(2), pp.144-151.
Munch, G. et al. 2000. SERCA2a activity correlates with the force-frequency relationship in human myocardium. American Journal of Physiology-Heart and Circulatory Physiology. 278(6), pp.H1924-H1932.
Valverde, C.A. et al. 2005. Frequency-dependent acceleration of relaxation in mammalian heart: a property not relying on phospholamban and SERCA2a phosphorylation. J Physiol. 562(Pt 3), pp.801-13.
Zhao, W. et al. 2004. Threonine-17 phosphorylation of phospholamban: a key determinant of frequency-dependent increase of cardiac contractility. Journal of Molecular and Cellular Cardiology. 37(2), pp.607-612.
Badrilla is a manufacturer of outstanding antibodies against cardiac proteins and phospho-proteins, and the manufacturer of leading kits for the study of protein S-palmitoylation.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.I agree